4.7 Article

Increasing numbers and complexity of Staphylococcus aureus bloodstream infectiond14 years of prospective evaluation at a German tertiary care centre with multi-centre validation of findings

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort study

Evelina Tacconelli et al.

Summary: The study aimed to develop scores to predict short-term and long-term mortality in patients with bloodstream infections, and validate them. Predictors for mortality included age, body-mass index, platelet and leukocyte counts, C-reactive protein concentrations, malignancy, in-hospital acquisition, and pathogen.

LANCET INFECTIOUS DISEASES (2022)

Article Infectious Diseases

Impact of neutropenia on clinical manifestations and outcome of Staphylococcus aureus bloodstream infection: a propensity score-based overlap weight analysis in two large, prospectively evaluated cohorts

Johannes Camp et al.

Summary: This study investigated the impact of neutropenia on the mortality and long-term outcomes of Staphylococcus aureus bloodstream infection. The results showed that neutropenia was not associated with a higher survival rate during follow-up, but neutropenic patients had a lower rate of SAB infection-related late complications.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Immunology

Risk Factors for Recurrent Staphylococcus aureus Bacteremia

Seong-Ho Choi et al.

Summary: This study identified several risk factors for R-SAB, with the highest risk observed among black hemodialysis patients. Higher levels of RANTES in R-SAB compared to matched controls suggest a need for further investigation.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Impact of Immunosuppressive Agents on Clinical Manifestations and Outcome of Staphylococcus aureus Bloodstream Infection: A Propensity Score-Matched Analysis in 2 Large, Prospectively Evaluated Cohorts

Johannes Camp et al.

Summary: The study suggests that immunosuppressive agents are not significantly associated with higher overall mortality in patients with Staphylococcus aureus bloodstream infection. However, specific immunosuppressive agents such as IMOTS may increase the risk of SAB-related late complications. Further investigations are needed on the use of specific immunosuppressive agents in SAB patients.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study

Richard Kuehl et al.

LANCET INFECTIOUS DISEASES (2020)

Review Infectious Diseases

Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review

Hilmir Asgeirsson et al.

INFECTIOUS DISEASES (2018)

Review Microbiology

Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology

Sahreena Lakhundi et al.

CLINICAL MICROBIOLOGY REVIEWS (2018)

Article Infectious Diseases

Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study

Cynthia T. Nguyen et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)

Review Microbiology

Predictors of Mortality in Staphylococcus aureus Bacteremia

Sebastian J. van Hal et al.

CLINICAL MICROBIOLOGY REVIEWS (2012)

Article Infectious Diseases

Healthcare-associated vs. hospital-acquired Staphylococcus aureus bacteremia

Jihad Bishara et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2012)

Article Immunology

Staphylococcus aureus bacteremia:: Predictors of 30-day mortality in a large cohort

JM Mylotte et al.

CLINICAL INFECTIOUS DISEASES (2000)